Dresden's OncoRay Center Gets World's First Single-Source PCCT Scanner for Cancer Treatment
Dresden's OncoRay Center has received a groundbreaking piece of equipment: the world's first single-source photon-counting computed tomography (PCCT) system for radiation therapy. Funded by the German Federal Ministry of Research, Technology and Space, this €2 million acquisition solidifies Dresden's position as a global leader in medical innovations and cancer research.
The PCCT scanner, set to be installed in the coming weeks and ready for clinical use by mid-July, promises enhanced precision and safety in cancer treatment. It generates more detailed, anatomically and functionally rich images, enabling more precise treatment planning, particularly for proton therapy. This not only improves patient care but also reduces the radiation dose they receive.
A significant advancement is the potential to treat moving tumors using the DirectSPR method. Previously, this method was only usable for stationary tumors. The PCCT scanner opens up new avenues in cancer treatment, further cementing Dresden's reputation as an internationally leading location for medical innovations.
The OncoRay Center in Dresden, the first worldwide to receive this innovative PCCT scanner, continues to push the boundaries of cancer research and treatment. With this €2 million investment from the Federal Ministry of Research, Technology and Space, Dresden reaffirms its commitment to advancing the field of radiation therapy and improving patient outcomes.
